THOUSANDS of lung cancer patients will have access to potentially life-saving immunotherapy cancer drugs, following a ruling by European health chiefs. The announcement, made last week by the European Commission, was prompted by a trial which showed that over two years patients with advanced lung cancer were 51 per cent more likely to survive with immune-boosting drugs than by standard treatment – at least doubling their 12-month life expectancy.
from Daily Express :: Health Feed http://bit.ly/2p9CFPh
via Buy Breast Actives
from Tumblr http://bit.ly/2D2bakv
No comments:
Post a Comment